117th Congress · SENATE BILLBILL

S. 1425 — Stop STALLING Act

“A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.”

Health

Introduced Apr 28, 2021

Last action Dec 8, 2021

Pipeline · Bill → Law

Step 1

Introduced

Apr 28, 2021

Step 2

Referred

Apr 28, 2021

the Judiciary

Step 3

Committee

Jul 29, 2021

Reported out

Step 4

Senate

Dec 8, 2021

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 3 sectionsReported to Senate

Timeline · 5 actions

Dec 8, 2021

Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.

Dec 8, 2021

Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.

Jul 29, 2021

Committee on the Judiciary. Ordered to be reported without amendment favorably.

Apr 28, 2021

Introduced in Senate

Apr 28, 2021

Read twice and referred to the Committee on the Judiciary.